
Paclitaxel Stragen is a brand of paclitaxel injection concentrate. Paclitaxel is also widely recognized by the brand name Taxol, but Taxol and Paclitaxel Stragen are not automatically interchangeable without an oncology pharmacist or doctor confirming the exact product, concentration, vial size and treatment protocol.
Paclitaxel belongs to the taxane group of chemotherapy medicines, also described as mitotic inhibitors. It works by interfering with microtubules inside cells, which are essential for cell division. Cancer cells that divide rapidly are therefore more likely to be affected, although normal fast-growing cells can also be harmed, which explains many side effects.
| FeatureDetails | |
| Brand | Paclitaxel Stragen |
| Active ingredient | Paclitaxel |
| Strength discussed | 6 mg/mL, 17 mL vial concentrate |
| Form | Sterile concentrate for intravenous infusion after dilution |
| Main use | Chemotherapy for selected cancers under specialist supervision |
The verified Vezeeta product page is available here: Paclitaxel Stragen 6 mg/mL vial on Vezeeta.
Paclitaxel is used in several oncology protocols. Recognized uses include ovarian cancer, breast cancer, non-small cell lung cancer and AIDS-related Kaposi’s sarcoma. In practice, it may be used alone or with other anticancer medicines depending on cancer type, stage, previous treatments, blood counts, liver function and the patient’s general condition.
One common search is Taxol for breast cancer. Paclitaxel-containing chemotherapy can be part of breast cancer treatment, including adjuvant treatment after other chemotherapy in some node-positive cases or treatment of metastatic disease after previous regimens. The exact role is decided by the oncology team, not by the drug name alone.
Paclitaxel may also be prescribed with platinum chemotherapy, such as carboplatin or cisplatin. Patients who need specialist follow-up or a second opinion can book an oncologist on Vezeeta.
Paclitaxel dose is not calculated like ordinary tablets. It is usually prescribed in milligrams per square meter of body surface area, then adjusted according to the cancer protocol, treatment cycle, liver tests, blood counts, nerve symptoms and previous toxicities.
Examples of adult schedules used in cancer protocols include 175 mg/m² by intravenous infusion over 3 hours every 3 weeks in some breast cancer settings, 135 to 175 mg/m² in ovarian cancer regimens, and 135 mg/m² over 24 hours followed by cisplatin in some non-small cell lung cancer protocols. These are general examples only; the treating oncologist may use different weekly or combination regimens.
Paclitaxel concentrate must be diluted before use and administered as an intravenous infusion by trained healthcare professionals. Premedication is commonly given before the infusion to reduce the risk of severe allergic reactions, and blood tests are usually checked before each cycle. Paclitaxel is not taken by mouth, so food does not control its absorption; however, the oncology team may give eating instructions to help reduce nausea. If an infusion appointment is missed, contact the oncology clinic promptly and do not change chemotherapy dates yourself.
Paclitaxel enters the bloodstream during the infusion, but the anti-cancer response is not judged immediately. Doctors usually assess response after several cycles using symptoms, examination, imaging and tumor markers when relevant. The medicine’s blood levels decline over hours to days, but effects on blood counts, nerves and cancer cells may last longer.
Paclitaxel side effects vary by dose, infusion duration, combination medicines and the patient’s health. Common or important effects include low white blood cells, anemia, low platelets, infection risk, hair loss, nausea, vomiting, diarrhea, mouth sores, tiredness, muscle or joint pain, numbness or tingling in the hands or feet, rash, flushing and injection-site reactions.
Some patients experience temporary changes in heart rate or blood pressure during infusion. Peripheral neuropathy may become dose-limiting if it becomes severe. Bone marrow suppression is an important reason for repeated blood-count monitoring. Seek urgent medical help during or after treatment for trouble breathing, swelling of the face or throat, widespread hives, severe dizziness, chest pain, fainting, fever, chills, signs of infection, unusual bleeding, severe mouth ulcers, severe diarrhea, worsening numbness or weakness, or painful swelling around the infusion site.
Paclitaxel should not be used in patients with a serious hypersensitivity to paclitaxel or to medicines formulated with polyoxyl castor oil. It should not be started when baseline neutrophil counts are below the accepted threshold for the relevant cancer type and protocol.
Important precautions include previous severe infusion reaction, low blood counts, active infection, liver impairment, significant heart conduction problems, existing peripheral neuropathy and the presence of alcohol in some paclitaxel formulations. Safety and effectiveness in children are not established for standard paclitaxel injection, so pediatric use requires specialist pediatric oncology judgment.
Paclitaxel is metabolized mainly through CYP2C8 and CYP3A4 pathways, so strong inhibitors or inducers of these enzymes may affect exposure or toxicity. Tell the doctor about all cancer medicines, antibiotics, antifungals, antivirals, seizure medicines, heart medicines, supplements and herbal products.
When paclitaxel is combined with cisplatin, the sequence can matter because more bone marrow suppression may occur if paclitaxel is given after cisplatin. With carboplatin, paclitaxel is commonly given first in many protocols to reduce interaction concerns and because the regimen has been studied that way. Doxorubicin combinations may require cardiac monitoring in selected patients.
Paclitaxel can harm an unborn baby and is generally contraindicated in pregnancy unless a specialist judges that the benefit outweighs the risk in a life-threatening situation. Effective contraception is usually required during treatment and for a period after the last dose as instructed by the oncology team.
Breastfeeding is contraindicated during paclitaxel therapy because anticancer medicines may pass into milk or harm the infant. Patients should discuss when breastfeeding can safely resume after treatment.
Paclitaxel is not taken every day like a chronic tablet. It is given in cycles, such as every week or every 3 weeks depending on the protocol. Long-term use is limited by cancer response, cumulative side effects, blood count recovery, nerve toxicity and overall treatment goals. Never continue, stop or delay cycles without oncology supervision.
Alternatives depend on the cancer type and previous therapy. They may include other taxanes such as docetaxel or nab-paclitaxel, platinum drugs such as carboplatin or cisplatin, anthracyclines, targeted therapies, immunotherapy, hormonal therapy, radiation or surgery. Substitution is not based on price or availability alone because different products have different dosing, toxicity and indications.
The price of Paclitaxel Stragen in Egypt can change with availability, pharmacy updates and pack supply. For the current listed product, check the verified Paclitaxel Stragen price and availability on Vezeeta Pharmacy. Chemotherapy medicines should be purchased from licensed sources and used only under medical supervision.
Paclitaxel is an intravenous chemotherapy medicine from the taxane group. It interferes with cell division and is used in selected cancer treatment protocols.
Both contain paclitaxel, but they may differ in brand, manufacturer, vial size and local availability. The oncology pharmacist should confirm substitution before any change.
It is used for cancers such as breast cancer, ovarian cancer, non-small cell lung cancer and Kaposi’s sarcoma, depending on the full treatment plan.
It is diluted and given by intravenous infusion in a hospital or chemotherapy unit, usually after premedication and blood-test review.
It stabilizes microtubules and prevents their normal breakdown, disrupting the cell-division process that cancer cells need to multiply.
They attack cancer cells through different mechanisms. The combination is used in several cancers because it may improve treatment activity compared with one drug in appropriate patients.
Many protocols give paclitaxel first because sequencing has been studied this way and may help manage interaction and toxicity concerns with platinum drugs.
The dose is commonly calculated from body surface area in mg/m², then adjusted for protocol, blood counts, liver function and side effects.
The cost depends on brand, vial size and availability. Check the verified pharmacy page and confirm the total treatment cost with the oncology unit.
Blood levels fall over hours to days, with reported half-life values varying by infusion schedule. Side effects such as low blood counts or nerve symptoms can last longer.
Paclitaxel is a natural product originally derived from yew tree sources and is manufactured today using controlled pharmaceutical processes.
Yes, hair loss is a common chemotherapy-related effect. Regrowth often occurs after treatment ends, but timing varies.
The information in this article is provided for general health education and does not replace medical advice from a doctor or pharmacist. Do not start, stop, or change the dose of any medication without consulting a qualified healthcare professional.
استشاري علاج الاورام وامراض الدم و الطب النووي طب الازهر
استشاري و مدرس علاج الأورام والكشف المبكر للاورام
إستشاري و دكتوراة في علاج الأورام و الطب النووي جامعة القاهرة القصر العيني
استشاري علاج الاورام وامراض الدم و الطب النووي طب الازهر
استشاري و مدرس علاج الأورام والكشف المبكر للاورام
إستشاري و دكتوراة في علاج الأورام و الطب النووي جامعة القاهرة القصر العيني